Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

DexCom, Inc. DXCM

Healthcare  —  Medical Devices
86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue 4,662.00 4,033.00 3,622.30 2,909.80 2,448.50 1,926.70 1,476.00 1,031.60 718.50 573.30
Revenue Growth 15.60% 11.34% 24.49% 18.84% 27.08% 30.54% 43.08% 43.58% 25.33% 42.61%
Cost of Revenue 1,860.10 1,594.80 1,333.40 1,026.70 768.00 646.60 544.50 367.70 226.40 194.90
Gross Profit 2,801.90 2,438.20 2,288.90 1,883.10 1,680.50 1,280.10 931.50 663.90 492.10 378.40
R&D Expenses 599.10 552.40 505.80 484.20 604.20 359.90 273.50 417.40 185.40 156.10
SG&A Expenses 1,291.00 1,285.80 1,185.40 1,007.70 810.50 618.20 515.70 432.80 349.20 286.20
Operating Income 911.80 600.00 597.70 391.20 265.80 299.50 142.30 (186.30) (42.50) (63.90)
Non-operating Income/Expense 176.60 109.00 112.70 (0.40) (9.00) (1.60) (38.10) 59.80 (6.10) (1.00)
Non-operating Interest Expenses — — — 18.60 18.80 17.70 60.30 22.70 12.80 0.70
EBT 1,088.40 709.00 710.40 390.80 256.80 297.90 104.20 (126.50) (48.60) (64.90)
Income Tax Provision 252.10 132.80 168.90 49.60 39.90 (251.80) 3.10 0.60 1.60 0.70
Income after Tax 836.30 576.20 541.50 341.20 216.90 549.70 101.10 (127.10) (50.20) (65.60)
Net Income Common 836.30 576.20 541.50 341.20 216.90 549.70 101.10 (127.10) (50.20) (65.60)
EPS (Basic) 2.14 1.46 1.40 0.88 0.56 1.31 0.28 (0.36) (0.14) (0.19)
EPS (Diluted) 2.09 1.42 1.30 0.82 0.39 1.27 0.28 (0.36) (0.14) (0.19)
Shares (Basic, Weighted) 390.20 393.60 386.00 389.40 386.90 377.50 364.40 352.80 345.20 334.40
Shares (Diluted, Weighted) 405.50 412.70 425.50 427.50 428.80 420.40 369.20 352.80 345.20 334.40
Gross Margin 60.10% 60.46% 63.19% 64.72% 68.63% 66.44% 63.11% 64.36% 68.49% 66.00%
EBIT Margin 19.56% 14.88% 16.50% 13.44% 10.86% 15.54% 9.64% (18.06%) (5.92%) (11.15%)
EBT margin 23.35% 17.58% 19.61% 13.43% 10.49% 15.46% 7.06% (12.26%) (6.76%) (11.32%)
Net Profit Margin 17.94% 14.29% 14.95% 11.73% 8.86% 28.53% 6.85% (12.32%) (6.99%) (11.44%)
Free Cash Flow Margin 23.11% 15.64% 14.13% 10.47% 111.07% 14.36% 9.11% 5.44% 3.62% 0.09%
EBITDA 1,163.60 817.70 783.70 547.10 367.80 366.60 191.00 (157.20) (26.40) (48.90)
EBIT 911.80 600.00 597.70 391.20 265.80 299.50 142.30 (186.30) (42.50) (63.90)
Income from Continuous Operations 836.30 576.20 541.50 341.20 216.90 549.70 101.10 (127.10) (50.20) (65.60)
Consolidated Net Income/Loss 836.30 576.20 541.50 341.20 216.90 549.70 101.10 (127.10) (50.20) (65.60)
EPS (Basic, from Continuous Ops) 2.14 1.46 1.40 0.88 0.56 1.46 0.28 (0.36) (0.15) (0.20)
EPS (Basic, Consolidated) 2.14 1.46 1.40 0.88 0.56 1.46 0.28 (0.36) (0.15) (0.20)
EPS (Diluted, from Cont. Ops) 2.06 1.40 1.27 0.80 0.51 1.31 0.27 (0.36) (0.15) (0.20)
Shares (Diluted, Average) 405.50 412.70 425.50 427.50 400.40 390.00 369.20 356.40 345.20 334.40
EPS (Diluted, Consolidated) 2.06 1.40 1.27 0.80 0.51 1.31 0.27 (0.36) (0.15) (0.20)
EBITDA Margin 24.96% 20.28% 21.64% 18.80% 15.02% 19.03% 12.94% (15.24%) (3.67%) (8.53%)
Operating Cash Flow Margin 30.90% 24.54% 20.66% 23.01% 18.07% 24.68% 21.31% 11.94% 12.80% 9.80%

Fold the line items

In millions of $ except per-share values · columns are period end dates